Anaplastic large-cell lymphoma with atypical chromosomal translocation t(2;5) and hypophyseal tumor

od Wang, Lei, Tong, Yin, Chen, Zhimei, Xu, Weilai, Jin, Jie
Izdano 2010

Downregulation of hTERT: An Important As(2)O(3) Induced Mechanism of Apoptosis in Myelodysplastic Syndrome

od Xu, Weilai, Wang, Yungui, Tong, Hongyan, Qian, Wenbin, Jin, Jie
Izdano u PLoS One (2014)

Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB

od XIAO, FENG, LI, YING, XU, WEILAI, YOU, LIANGSHUN, YANG, CHUNMEI, LIU, HUI, QIAN, WENBIN
Izdano u Oncol Lett (2016)

Acute myocardial/cerebral infarction as first/relapse manifestation in one acute promyelocytic leukemia patient

od Li, Ying, Suo, Shanshan, Mao, Liping, Wang, Lei, Yang, Chunmei, Xu, Weilai, Lou, Yinjun, Mai, Wenyuan
Izdano u Int J Clin Exp Med (2015)

Lower-dose decitabine improves clinical response compared with best supportive care in lower-risk MDS patients: a prospective, multicenter phase 2 study

od Ye, Li, Mei, Chen, Ren, Yanling, Zhou, Xinping, Ma, Liya, Xu, Weilai, Wei, Juying, Jiang, Huifang, Zhang, Liming, Zeng, Hui, Tong, Hongyan
Izdano u J Cancer (2021)

Real‐world data of chronic myelomonocytic leukemia: A chinese single‐center retrospective study

od Ma, Liya, Jiang, Lingxu, Yang, Wenli, Luo, Yingwan, Mei, Chen, Zhou, Xinping, Xu, Gaixiang, Xu, Weilai, Ye, Li, Ren, Yanlin, Lu, Chenxi, Lin, Peipei, Jin, Jie, Tong, Hongyan
Izdano u Cancer Med (2021)

Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes

od Jiang, Lingxu, Luo, Yingwan, Zhu, Shuanghong, Wang, Lu, Ma, Liya, Zhang, Hua, Shen, Chuying, Yang, Wenli, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Izdano u Cancer Sci (2019)

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes

od Yan, Xuefen, Wang, Lu, Jiang, Lingxu, Luo, Yingwan, Lin, Peipei, Yang, Wenli, Ren, Yanling, Ma, Liya, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Gaixiang, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Izdano u Cancer Med (2021)

Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes

od Jiang, Lingxu, Wang, Lu, Shen, Chuying, Zhu, Shuanghong, Lang, Wei, Luo, Yingwan, Zhang, Hua, Yang, Wenli, Han, Yueyuan, Ma, Liya, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Izdano u Am J Cancer Res (2020)

Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone

od Ye, Li, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ma, Liya, Ye, Xingnong, Wei, Juying, Xu, Weilai, Meng, Haitao, Qian, Wenbin, Mai, Wenyuan, Lou, Yinjun, Xu, Gaixiang, Qian, Jiejing, Lou, Yejiang, Luo, Yingwan, Xie, Lili, Lin, Peipei, Hu, Chao, Jin, Jie, Tong, Hongyan
Izdano u J Cancer Res Clin Oncol (2017)

The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes

od Lin, Peipei, Ren, Yanling, Yan, Xiaomei, Luo, Yingwan, Zhang, Hua, Kesarwani, Meenu, Bu, Jiachen, Zhan, Di, Zhou, Yile, Tang, Yuting, Zhu, Shuanghong, Xu, Weilai, Zhou, Xinping, Mei, Chen, Ma, Liya, Ye, Li, Hu, Chao, Azam, Mohammad, Ding, Wei, Jin, Jie, Huang, Gang, Tong, Hongyan
Izdano u Haematologica (2019)